期刊文献+

子宫腺肌病与子宫肌瘤临床特征对比分析 被引量:6

Comparison and analysis of the clinical features of adenomyosis and uterine myoma
暂未订购
导出
摘要 目的比较子宫腺肌病与子宫肌瘤的,晦床特征,以提高子宫腺肌病诊断水平。方法比较子宫腺肌病及子宫肌瘤各42例患者的发病情况、年龄分布、主要临床症状、宫腔操作史、妇检、B超图像、癌抗原125等方面的差异。结果两组宫腔操作史、进行性痛经、贫血、子宫增大、有触痛的发生率比较差异均有统计学意义(X2值分别为17.56、56.78、9.56、48.45、39.56,均P〈0.05);子宫腺肌病组癌抗原125值(67.12±12.45)kIU/L高于子宫肌瘤组(12.56±3.67)kIU/L(t=9.46,P〈0.05);B超检查图像显示,两组子宫均匀增大经期明显、病灶内条状或点状彩色血流信号散在分布和假包膜形成及界限清楚的发生率比较差异均有统计学意义x2值分别为67.34、43.25、52.23,均P〈0.05)。结论子宫腺肌病·临床表现对诊断具有重要的参考价值,结合B超检测可以提高诊断率。 Objective To compare the clinical features of adenomyosis and uterine myoma, so as to improve the diagnosis level of adenomyosis. Methods Pathogenesis, age distribution, major clinical symptoms, history of intrauterine operation, gynecological examination, B-scan ultrasonic image and carcinoma antigen 125 (CA125) were compared between adenomyosis group (n = 42) and uterine myoma group (n = 42 ). Results There were statistical differences between two groups in history of intrauterine operation, dysmenorrheal, anemia, uterine enlargement and tenderness (X2 value was 17.56, 56.78, 9.56, 48.45 and 39.56, respectively, all P 〈 0.05). The value of CA125 of adenomyosis group was higher than that of uterine myoma group (67.12 ±12.45 vs 12.56 ± 3.67) (t = 9.46,P 〈 0. 05 ). B-scan ultrasonic images indicated that there were significant differences in the incidence of significant uterus enlargement, scattering of intralesional strips or spots of color Doppler signals and pseudocapsule formation and clear boundaries between two groups (X2 value was 67.34, 43.25 and 52.23, respectively, all P 〈 0.05 ). Conclusion Clinical manifestations of adenomyosis is of great reference value on its diagnosis. The diagnosis rate can be improved when B-ultrasonography is combined.
作者 陈芳
出处 《中国妇幼健康研究》 2013年第2期263-264,275,共3页 Chinese Journal of Woman and Child Health Research
关键词 子宫腺肌病 子宫肌瘤 临床特征 B超检查 adenomyosis uterine myoma clinical features B-ultrasonography
  • 相关文献

参考文献9

二级参考文献46

  • 1祝云平.子宫腺肌病的诊治进展[J].中国现代药物应用,2007,1(1):46-47. 被引量:5
  • 2彭超,周应芳.子宫腺肌症318例诊治分析[J].中国妇产科临床杂志,2001,2(2):72-74. 被引量:45
  • 3江森.子宫内膜异位症研究的进展[J].中华妇产科杂志,1994,29(10):624-627. 被引量:65
  • 4程国钧,郑建京.子宫内膜异位症[J].中华妇产科杂志,1995,30(3):189-191. 被引量:20
  • 5Barbieri RL.CA125 in patients with endometriosis[J].Fertil Steril,1986,45(6):767-769.
  • 6Krasnicki D.Serum and peritoneal fluid CA125 concentration in women with endometriosis[J].Ginekol Pol,2001,72(12):1365-1372.
  • 7Mathur S,Peress MR,Williamson HO,et al.Autoimmunity to endometrium and ovary in endometriosis[J].Clin Exp Immunol,1982,50(6):259-231.
  • 8Kaupp A,Jonath S.Changing concepts of medical treatment of endometriosis[J].Acta Obstet Gynecol Scand,1999,89(11):245-266.
  • 9Takahashi K,Kitao M,Okada S,et al.Serum CA125 and EMAb in evaluating patients with endometrioma prior to medical therapy[J].Fertil Steril,1996,65(1):288-292.
  • 10Gilks BC,Clement PB,Hart WR,et al.Uterine adenomyomas excluding atypical polypoid adenomyomas and adenomyomas of endocervical type:a clinicopathologic study of 30 cases of an underemphasized lesion that may cause diagnostic problems with brief consideration of adenomyomas of other female genital tract sites[J].Int J Cynecol Pathol,2000,19(3):195-205.

共引文献83

同被引文献62

  • 1沈茂平,陈芳.中药内服加足浴治疗痛经46例[J].新疆中医药,2006,24(4):30-30. 被引量:3
  • 2蔡云朗,沈扬,任慕兰,赵维英,姚青,何杰,李嘉,翟卫中.米非司酮对子宫肌瘤组织中雌、孕激素受体及表皮生长因子受体的影响[J].现代医学,2007,35(4):299-303. 被引量:24
  • 3曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1999.2129.
  • 4国家中医药管理局.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:29.
  • 5Van den Bosch T, Coosemans A, Morina M, et al. Screening for uterine tumors E J ]. Best Pract Res Clin Obstet Gynaecol, 2012,26 (2) :257-266.
  • 6Levy G, Hill M J, Beal] S, et al. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances [ J ]. J Assist Reprod Genet, 2012,29 ( 8 ) : 703 -712.
  • 7Rabinovici J, David M, Fukunishi H, et al. Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery ( MRgFUS ) for conservative treatment of uterine fibroids[ J]. Fertil Steril,2010, 93 ( 1 ) : 199-209.
  • 8Rekawiecki R,Kowalik MK,Kotwica J.Onapristone(ZK299)and mifepristone(RU486)regulate the messenger RNA and protein expression levels of the progesterone receptor isoforms A and B in the bovine endometrium[J].Theriogenology,2015,84(3):348-357.
  • 9Yerushalmi GM,Gilboa Y,Jakobson-Setton A,et al.Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata:an open-label study[J].Fertility and Sterility,2014,101(2):496-500.
  • 10Homg HC, Chen CH, Chen CY, et al. Uterine - sparing surgery for adenomyosis and/or adenomyoma [ J ]. Taiwan Residents J Obstet Gyneeol, 2014,53(1) :3 -7.

引证文献6

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部